Impact on imports and exports to France
The practical impact of the French measure is significant. For importers of products from third countries, it means that they can no longer rely solely on compliance with EU MRLs. They must demonstrate that products for the French market are free of residues of the substances in question above the detection limit. This will require tightened contracts with suppliers, additional laboratory analyses and possibly adjustment of cultivation practices in the country of origin.
Additional obligations also arise for EU exporters when delivering to France. Although products can circulate freely in other member states, France may carry out additional checks upon entry. This results in additional administrative burdens and a higher risk of trade barriers.
For international trading partners, the French measure may trigger discussions within WTO rules, as differences between EU harmonization and national additions affect the predictability of market access.
The French MRL measure illustrates that harmonization within the EU does not preclude Member States from imposing stricter national requirements in exceptional circumstances. Although the EU provides a uniform residue framework through Regulation (EC) No. 396/2005, there remains room for national intervention when Member States wish to provide additional public health protection.